Literature DB >> 17318909

Dependence on glucose limitation of the pCO2 influences on CHO cell growth, metabolism and IgG production.

Shinya Takuma1, Chikashi Hirashima, James M Piret.   

Abstract

The culture levels of glucose and CO(2) have been reported to independently have important influences on mammalian cell processes. In this work the combined effects of glucose limitation and CO(2) partial pressure (pCO(2)) on monoclonal antibody (IgG) producing Chinese Hamster Ovary cells were investigated in a perfusion reactor operated with controlled cell specific medium feed rate, pH and osmolality. Under high glucose conditions (14.3 +/- 0.8 mM), the apparent growth rate decreased (from 0.021 to 0.009 h(-1)) as the pCO(2) increased to approximately 220 mmHg, while the cell specific IgG productivity was almost unchanged. The lactate yield from glucose was not affected by pCO(2) up to approximately 220 mmHg and glucose was mainly converted to lactate. A feed medium modification from high (33 mM) to low (6 mM) glucose resulted in <0.1 mM glucose in the culture. As a result of apparently shifting metabolism towards the conversion of pyruvate to CO(2), both the ratio of lactate to glucose and the alanine production rate were lowered (1.51-1.14 and 17.7-0.56 nmol/10(6) cells h, respectively). Interestingly, when the pCO(2) was increased to approximately 140 mmHg, limiting glucose resulted in 1.7-fold higher growth rates, compared to high glucose conditions. However, at approximately 220 mmHg pCO(2) this beneficial effect of glucose limitation on these CHO cells was lost as the growth rate dropped dramatically to 0.008 h(-1) and the IgG productivity was lowered by 15% (P < 0.01) relative to the high glucose condition. The IgG galactosylation increased under glucose- limited compared to high-glucose conditions. (c) 2007 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318909     DOI: 10.1002/bit.21376

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  6 in total

1.  Optimization of bioprocess conditions improves production of a CHO cell-derived, bioengineered heparin.

Authors:  Jong Youn Baik; Hussain Dahodwala; Eziafa Oduah; Lee Talman; Trent R Gemmill; Leyla Gasimli; Payel Datta; Bo Yang; Guoyun Li; Fuming Zhang; Lingyun Li; Robert J Linhardt; Andrew M Campbell; Stephen F Gorfien; Susan T Sharfstein
Journal:  Biotechnol J       Date:  2015-06-24       Impact factor: 4.677

2.  Synergizing metabolic flux analysis and nucleotide sugar metabolism to understand the control of glycosylation of recombinant protein in CHO cells.

Authors:  Susan C Burleigh; Teun van de Laar; Corné J M Stroop; Wout M J van Grunsven; Niaobh O'Donoghue; Pauline M Rudd; Gavin P Davey
Journal:  BMC Biotechnol       Date:  2011-10-18       Impact factor: 2.563

3.  Very high density of CHO cells in perfusion by ATF or TFF in WAVE bioreactor™. Part I. Effect of the cell density on the process.

Authors:  Marie-Françoise Clincke; Carin Mölleryd; Ye Zhang; Eva Lindskog; Kieron Walsh; Véronique Chotteau
Journal:  Biotechnol Prog       Date:  2013-05-21

4.  Investigation of cell line specific responses to pH inhomogeneity and consequences for process design.

Authors:  Katrin Paul; Thomas Hartmann; Christoph Posch; Dirk Behrens; Christoph Herwig
Journal:  Eng Life Sci       Date:  2020-07-21       Impact factor: 2.678

5.  The influence of serum, glucose and oxygen on intervertebral disc cell growth in vitro: implications for degenerative disc disease.

Authors:  William E B Johnson; Simon Stephan; Sally Roberts
Journal:  Arthritis Res Ther       Date:  2008-04-23       Impact factor: 5.156

Review 6.  CO2 - Intrinsic Product, Essential Substrate, and Regulatory Trigger of Microbial and Mammalian Production Processes.

Authors:  Bastian Blombach; Ralf Takors
Journal:  Front Bioeng Biotechnol       Date:  2015-08-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.